Charlotte Harrison

I’m an experienced science writer who focuses on drug discovery, biotechnology and pharmacology.

I’ve worked with Nature Biotechnology, Nature Medicine, Nature Reviews Drug Discovery, Nature Outlook, Lab Animal, Drug Hunter, Frontline Genomics, the Bracken Group, the Eureka Institute, Nature Research Editing Services, BioEdit and individual researchers.

Examples of my writing include:

Six key developments in the fight against antimicrobial resistance | Nature Outlook
Newcomer anti-IL-33 makes strides in COPD | Nature Biotechnology
New approach methodologies gain momentum, providing human-relevant alternatives to animal models | Lab Animal
Can amylin-based drugs upstage GLP-1 agonists? | Nature Biotechnology
Biopharma dives into tutor-seeking radioactive drugs | Nature Biotechnology 
Vertex’s opioid-free drug for acute pain wins FDA approval | Nature Biotechnology
CRISPR Nobelists surrender their own European patents | Nature Biotechnology
TCR cell therapies vanquish solid tumors — finally | Nature Biotechnology
CAR-T cells sweep into autoimmunity | Nature Biotechnology
3R centers tap into the human mindset to bolster replacement, reduction and refinement uptake | Lab Animal
Hair loss treatments target the immune system | Nature Biotechnology
Shared science’s time to shine | Lab Animal
Innovators hit by ruling in dispute over cholesterol antibody patent | Nature Biotechnology
Mice on the move | Lab Animal
My mix-and-match career | Science
Why did Bristol Myers Squibb pay $4.1bn for Turning Point Therapeutics? | Drug Hunter
How enzymes turn biology into technology | A resource for students aged 16–18 years
First gene therapy for β-thalassemia approved | Nature Biotechnology
Monkeypox response relies on three vaccine suppliers | Nature Biotechnology
Coronavirus puts drug repurposing on the fast track | Nature Biotechnology
Drug researchers pursue new lines of attack against COVID-19 | Nature Biotechnology
Focus shifts to antibody cocktails for COVID-19 cytokine storm | Nature Biotechnology
This cell will self-destruct in 5 days | Frontline Genomics

I also write:
News briefs | Research highlights | Case studies | Newsletters | Q&As 

I also provide high-quality, developmental editing of research manuscripts, reviews and grant applications.

 “The authors of the grant application you edited were thrilled and mentioned that your editing elevated the document significantly. So thank you very much for your hard work on that project!” Feedback from a client about my work on a grant application.

I hold a PhD in pharmacology from the University of Leicester and have completed postdoctoral positions at the University of Michigan and Pfizer. I worked as an in-house editor at Springer Nature before going freelance. I’m a member of the British Association of Science Writers. I live in Canterbury, a small city with a big cathedral in the south-east corner of the UK.